Eyebright Medical Technology Hits Day Low Amid Price Pressure at CNY 56.66

Eyebright Medical Technology (Beijing) Co., Ltd. experienced a notable decline today, with the stock dropping by 4.24% on March 3, 2026. The stock reached an intraday low of CNY 56.66, reflecting ongoing challenges in its market performance. Over the past week, the stock has decreased by 4.81%, while its one-month performance shows a decline of 4.53%. In a broader context, Eyebright Medical has faced significant underperformance compared to the China Shanghai Composite, which has gained 0.41% over the same week. Year-to-date, the stock is down 5.75%, and its one-year performance reveals a substantial drop of 40.29%. Key financial metrics indicate a market capitalization of CNY 11,266 million, with a price-to-earnings ratio of 35.00. The company's return on equity stands at 12.86%, and it has a price-to-book ratio of 4.01. Despite a 20.2% increase in profits over the past year, the stock's performance has not aligned with the broader market trends, highlighting a consistent pattern of underperformance.